These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA. Garrison MW; Kawamura NM; Wen MM Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1087-103. PubMed ID: 23167512 [TBL] [Abstract][Full Text] [Related]
6. Ceftaroline: a new cephalosporin with activity against resistant gram-positive pathogens. Steed ME; Rybak MJ Pharmacotherapy; 2010 Apr; 30(4):375-89. PubMed ID: 20334458 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010). Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953 [TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamics of ceftaroline fosamil for complicated skin and skin structure infection: rationale for improved anti-methicillin-resistant Staphylococcus aureus activity. Drusano GL J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv33-9. PubMed ID: 21115453 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010). Sader HS; Flamm RK; Jones RN Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208 [TBL] [Abstract][Full Text] [Related]
13. Ceftaroline fosamil: drug profile and clinical data. Kanafani ZA Future Microbiol; 2011 Jan; 6(1):9-18. PubMed ID: 21162631 [TBL] [Abstract][Full Text] [Related]
14. Ceftaroline fosamil (Teflaro) - a new IV cephalosporin. Med Lett Drugs Ther; 2011 Jan; 53(1356):5-6. PubMed ID: 21252841 [No Abstract] [Full Text] [Related]
17. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model. Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940 [TBL] [Abstract][Full Text] [Related]
18. Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection. Parish D; Scheinfeld N Curr Opin Investig Drugs; 2008 Feb; 9(2):201-9. PubMed ID: 18246523 [TBL] [Abstract][Full Text] [Related]
19. Ceftaroline: a comprehensive update. Kaushik D; Rathi S; Jain A Int J Antimicrob Agents; 2011 May; 37(5):389-95. PubMed ID: 21420284 [TBL] [Abstract][Full Text] [Related]
20. Activity of the new cephalosporin ceftaroline against bacteraemia isolates from patients with community-acquired pneumonia. Morrissey I; Ge Y; Janes R Int J Antimicrob Agents; 2009 Jun; 33(6):515-9. PubMed ID: 19203863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]